cell analysis
The firm is commercializing an instrument to more easily, directly, and quickly measure cell therapy potency with the help of a recent SBIR grant.
PAK4 Inhibition Increases Anti-PD-1 Response in Mouse Models Prompting Phase I Trial
Researchers tested the combined treatment in mice, after detecting increased PAK4 expression and reduced immune infiltration in melanoma patients with poor anti-PD-1 response.